M14-430
ClinicalTrials.gov NCT03345823
Research payments
$3,122,698
Through program year 2020, $3,122,698 in research payments was reported against M14-430, across 875 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03345823
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $2,088,698 | 525 |
| 2019 | Research | $1,034,001 | 350 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Edward Loftus Rochester, MN Named on 28 payments
- Suzy Kim Greenville, SC Named on 27 payments
- Sara Horst Nashville, TN Named on 26 payments
- Jonathan Siegel Mobile, AL Named on 25 payments
- Michael Bennett San Diego, CA Named on 24 payments
- Henry Levine Orlando, FL Named on 23 payments
- George Duvall Vero Beach, FL Named on 21 payments
- Robert Wohlman Bellevue, WA Named on 20 payments
- Charles Johnson Mobile, AL Named on 20 payments
- Louis Korman Chevy Chase, MD Named on 19 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.